Overexpression of Specific CD44 Isoforms Is Associated with Aggressive Cell Features in Acquired Endocrine Resistance

While endocrine therapy is the mainstay of ER+ breast cancer, the clinical effectiveness of these agents is limited by the phenomenon of acquired resistance that is associated with disease relapse and poor prognosis. Our previous studies revealed that acquired resistance is accompanied by a gain in...

Descripción completa

Detalles Bibliográficos
Autores principales: Bellerby, Rebecca, Smith, Chris, Kyme, Sue, Gee, Julia, Günthert, Ursula, Green, Andy, Rakha, Emad, Barrett-Lee, Peter, Hiscox, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913094/
https://www.ncbi.nlm.nih.gov/pubmed/27379207
http://dx.doi.org/10.3389/fonc.2016.00145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913094/
https://www.ncbi.nlm.nih.gov/pubmed/27379207
http://dx.doi.org/10.3389/fonc.2016.00145

Ejemplares similares